RGD Reference Report - Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity.

Authors: Copeland, RJ  Bullen, JW  Hart, GW 
Citation: Copeland RJ, etal., Am J Physiol Endocrinol Metab. 2008 Jul;295(1):E17-28. Epub 2008 Apr 29.
RGD ID: 2311625
Pubmed: PMID:18445751   (View Abstract at PubMed)
PMCID: PMC3751035   (View Article at PubMed Central)
DOI: DOI:10.1152/ajpendo.90281.2008   (Journal Full-text)

O-linked beta-N-acetylglucosamine (O-GlcNAc) is a dynamic posttranslational modification that, analogous to phosphorylation, cycles on and off serine and/or threonine hydroxyl groups. Cycling of O-GlcNAc is regulated by the concerted actions of O-GlcNAc transferase and O-GlcNAcase. GlcNAcylation is a nutrient/stress-sensitive modification that regulates proteins involved in a wide array of biological processes, including transcription, signaling, and metabolism. GlcNAcylation is involved in the etiology of glucose toxicity and chronic hyperglycemia-induced insulin resistance, a major hallmark of type 2 diabetes. Several reports demonstrate a strong positive correlation between GlcNAcylation and the development of insulin resistance. However, recent studies suggest that inhibiting GlcNAcylation does not prevent hyperglycemia-induced insulin resistance, suggesting that other mechanisms must also be involved. To date, proteomic analyses have identified more than 600 GlcNAcylated proteins in diverse functional classes. However, O-GlcNAc sites have been mapped on only a small percentage (<15%) of these proteins, most of which were isolated from brain or spinal cord tissue and not from other metabolically relevant tissues. Mapping the sites of GlcNAcylation is not only necessary to elucidate the complex cross-talk between GlcNAcylation and phosphorylation but is also key to the design of site-specific mutational studies and necessary for the generation of site-specific antibodies, both of which will help further decipher O-GlcNAc's functional roles. Recent technical advances in O-GlcNAc site-mapping methods should now finally allow for a much-needed increase in site-specific analyses to address the functional significance of O-GlcNAc in insulin resistance and glucose toxicity as well as other major biological processes.

Molecular Pathway Annotations    Click to see Annotation Detail View

RGD Manual Annotations

TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
hexosamine biosynthetic pathway   TAS 2311625; 2311625; 2311625; 2311625; 2311625 RGD 
hexosamine biosynthetic pathway   ISOOga (Rattus norvegicus)2311625 RGD 
Objects Annotated

Genes (Rattus norvegicus)
Oga  (O-GlcNAcase)
Ogt  (O-linked N-acetylglucosamine (GlcNAc) transferase)

Genes (Mus musculus)
Oga  (O-GlcNAcase)
Ogt  (O-linked N-acetylglucosamine (GlcNAc) transferase (UDP-N-acetylglucosamine:polypeptide-N-acetylglucosaminyl transferase))

Genes (Homo sapiens)
OGA  (O-GlcNAcase)
OGT  (O-linked N-acetylglucosamine (GlcNAc) transferase)


Additional Information